(Q69738719)

English

Synergistic induction of lymphokine (IL-2)-activated killer activity by IL-2 and the polysaccharide lentinan, and therapy of spontaneous pulmonary metastases

scientific article published on 01 January 1989

In more languages

Statements

scholarly article

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:2785852%20AND%20SRC:MED&resulttype=core&format=json

5 October 2019

Synergistic induction of lymphokine (IL-2)-activated killer activity by IL-2 and the polysaccharide lentinan, and therapy of spontaneous pulmonary metastases (English)

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:2785852%20AND%20SRC:MED&resulttype=core&format=json

5 October 2019

1 reference

based on heuristic

inferred from title

author name string

K Yamasaki

1

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:2785852%20AND%20SRC:MED&resulttype=core&format=json

5 October 2019

S Sone

2

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:2785852%20AND%20SRC:MED&resulttype=core&format=json

5 October 2019

T Yamashita

3

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:2785852%20AND%20SRC:MED&resulttype=core&format=json

5 October 2019

T Ogura

4

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:2785852%20AND%20SRC:MED&resulttype=core&format=json

5 October 2019

publication date

1 January 1989

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:2785852%20AND%20SRC:MED&resulttype=core&format=json

5 October 2019

Cancer Immunology, Immunotherapy

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:2785852%20AND%20SRC:MED&resulttype=core&format=json

5 October 2019

29

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:2785852%20AND%20SRC:MED&resulttype=core&format=json

5 October 2019

2

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:2785852%20AND%20SRC:MED&resulttype=core&format=json

5 October 2019

87-92

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:2785852%20AND%20SRC:MED&resulttype=core&format=json

5 October 2019

https://scigraph.springernature.com/pub.10.1007/bf00199282

0 references

Role of alveolar macrophages in pulmonary neoplasias

1 reference

https://pubmed.ncbi.nlm.nih.gov/2785852

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Lymphokine-activated killer cells. Analysis of progenitors and effectors

1 reference

https://pubmed.ncbi.nlm.nih.gov/2785852

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Interleukin-2 augments natural killer cell activity

1 reference

https://pubmed.ncbi.nlm.nih.gov/2785852

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

The anti-tumor efficacy of lymphokine-activated killer cells and recombinant interleukin 2 in vivo

1 reference

https://pubmed.ncbi.nlm.nih.gov/2785852

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Beta (1-3) glucans as a probe for T cell specific immune adjuvants. II. Enhanced in vitro generation of cytotoxic T lymphocytes

1 reference

https://pubmed.ncbi.nlm.nih.gov/2785852

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Effect of a thymic factor, thymostimulin, on growth and pulmonary metastases of Lewis lung carcinoma

1 reference

https://pubmed.ncbi.nlm.nih.gov/2785852

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Regression of established pulmonary metastases and subcutaneous tumor mediated by the systemic administration of high-dose recombinant interleukin 2.

1 reference

https://pubmed.ncbi.nlm.nih.gov/2785852

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Adoptive Immunotherapy of Established Pulmonary Metastases with LAK Cells and Recombinant Interleukin-2

1 reference

https://pubmed.ncbi.nlm.nih.gov/2785852

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Successful immunotherapy of murine experimental hepatic metastases with lymphokine-activated killer cells and recombinant interleukin 2.

1 reference

https://pubmed.ncbi.nlm.nih.gov/2785852

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Lymphokine-activated killer cell phenomenon. II. Precursor phenotype is serologically distinct from peripheral T lymphocytes, memory cytotoxic thymus-derived lymphocytes, and natural killer cells

1 reference

https://pubmed.ncbi.nlm.nih.gov/2785852

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Antitumor activity of lentinan in murine syngeneic and autochthonous hosts and its suppressive effect on 3-methylcholanthrene-induced carcinogenesis.

1 reference

https://pubmed.ncbi.nlm.nih.gov/2785852

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Macrophages and metastasis--a biological approach to cancer therapy

1 reference

https://pubmed.ncbi.nlm.nih.gov/2785852

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Constant-infusion recombinant interleukin-2 in adoptive immunotherapy of advanced cancer

1 reference

https://pubmed.ncbi.nlm.nih.gov/2785852

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Heterogeneity of human lymphokine (IL-2)-activated killer (LAK) precursors and regulation of their LAK induction by blood monocytes.

1 reference

https://pubmed.ncbi.nlm.nih.gov/2785852

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Lymphokine-activated killer cell phenomenon. Lysis of natural killer-resistant fresh solid tumor cells by interleukin 2-activated autologous human peripheral blood lymphocytes

1 reference

https://pubmed.ncbi.nlm.nih.gov/2785852

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Fractionation and purification of the polysaccharides with marked antitumor activity, especially lentinan, from Lentinus edodes (Berk.) Sing. (an edible mushroom)

1 reference

https://pubmed.ncbi.nlm.nih.gov/2785852

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Immunotherapy of Madison 109 lung carcinoma and other murine tumors using lentinan

1 reference

https://pubmed.ncbi.nlm.nih.gov/2785852

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

In vivo anti-tumor activity of combinations of interferon alpha and interleukin-2 in a murine model. Correlation of efficacy with the induction of cytotoxic cells resembling natural killer cells

1 reference

https://pubmed.ncbi.nlm.nih.gov/2785852

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Induction of cytotoxic peritoneal exudate cells by T-cell immune adjuvants of the beta(1 leads to 3) glucan-type lentinan and its analogues

1 reference

https://pubmed.ncbi.nlm.nih.gov/2785852

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Interleukin 2 induces gamma-interferon production: participation of macrophages and NK-like cells

1 reference

https://pubmed.ncbi.nlm.nih.gov/2785852

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Immunotherapy of murine sarcomas using lymphokine activated killer cells: optimization of the schedule and route of administration of recombinant interleukin-2

1 reference

https://pubmed.ncbi.nlm.nih.gov/2785852

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Observations on the systemic administration of autologous lymphokine-activated killer cells and recombinant interleukin-2 to patients with metastatic cancer

1 reference

https://pubmed.ncbi.nlm.nih.gov/2785852

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Enhanced metastatic potential of cloned low-metastatic Lewis lung carcinoma cells treated in vitro with dimethyl sulfoxide

1 reference

https://pubmed.ncbi.nlm.nih.gov/2785852

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Antitumor Polysaccharide Lentinan—A T Cell Adjuvant2

1 reference

https://pubmed.ncbi.nlm.nih.gov/2785852

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

A progress report on the treatment of 157 patients with advanced cancer using lymphokine-activated killer cells and interleukin-2 or high-dose interleukin-2 alone

1 reference

https://pubmed.ncbi.nlm.nih.gov/2785852

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Interleukin 2-activated human killer cells are derived from phenotypically heterogeneous precursors.

1 reference

https://pubmed.ncbi.nlm.nih.gov/2785852

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Augmentative effect of Nocardia rubra cell-wall skeleton (N-CWS) on lymphokine-activated killer (LAK) cell induction

1 reference

https://pubmed.ncbi.nlm.nih.gov/2785852

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

The fate of interleukin-2 after in vivo administration

1 reference

https://pubmed.ncbi.nlm.nih.gov/2785852

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Synergistic effects of combination therapy with human recombinant interleukin-2 and tumor necrosis factor in murine tumor models

1 reference

https://pubmed.ncbi.nlm.nih.gov/2785852

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Identifiers

Sitelinks

Wikipedia(0 entries)

Wikibooks(0 entries)

Wikinews(0 entries)

Wikiquote(0 entries)

Wikisource(0 entries)

Wikiversity(0 entries)

Wikivoyage(0 entries)

Wiktionary(0 entries)

Multilingual sites(0 entries)

Retrieved from "https://www.wikidata.org/w/index.php?title=Q69738719&oldid=2159383151"